Cardiotoxicity risk with bortezomib versus lenalidomide for...

  • Main
  • 2016 / 11
  • Cardiotoxicity risk with bortezomib versus lenalidomide for...

Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients

Reneau, John C., Asante, Dennis, Van Houten, Holly, Sangaralingham, Lindsey R., Buadi, Francis K., Lerman, Amir, Herrmann, Joerg
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.24599
Date:
November, 2016
File:
PDF, 714 KB
english, 2016
Conversion to is in progress
Conversion to is failed